Aspen Europe News

Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, is pleased to announce that it has successfully concluded an exclusive licensing agreement with the Republic of Korea-based Wooshin Labottach Co. LTD, for Lidocaine 700mg medicated plasters, in selected European Union (EU) markets.

Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, has concluded an exclusive licensing agreement (“Agreement”) with Swiss-based Devintec Pharma (“Devintec”) for Europe.  The Agreement is for a unique patented European Union-registered Medical Device Class II for the treatment of vaginal infections and…